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ABSTRACT 
 
Prions are infectious proteins that are autocatalyzing (formed by altering a regular protein into the 
structurally different prion form), and are associated with many neurodegenerative diseases such as 
Alzheimer’s, Parkinson’s, Huntington’s, and Bovine Spongiform encephalopathy (or Mad Cow disease). 
This experiment tested the effect of three different plasmids—pH317, pER62, and pMP46—on prion 
formation in both wild-type and Urm1 deletion mutants in the yeast Saccharomyces cerevisiae. The 
proposed hypothesis was over-expression of the Ure2 prion forming protein would increase the frequency 
of prion formation, as well as yield less sustainable prion amyloids (or prion aggregations) that are 
easier to cure. Another purpose of this experiment was to investigate how the presence or absence of the 
URM1 gene affects the overall formation of prions. The data showed that over-expression of proteins was 
seen to increase prion formation, and that over-expression yielding prions were less sustainable across 
generations. Also shown was that deletion mutants yielded higher numbers of prions than their wild-type 
counterparts.Curing through use of over-expression and guanidine, which inhibits the chaperone proteins 
associated with dividing prions during cellular division, proved inconclusive because there was no visible 
difference between any of the three plasmids. 
 
Introduction 
 
Prions are infectious proteins that are autocatalyzing (formed by altering a regular protein into the 
structurally different prion form), and are associated with many neurodegenerative diseases such as 
Alzheimer’s, Parkinson’s, Huntington’s, and Bovine Spongiform encephalopathy (or Mad Cow disease). 
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Initially, prions were studied because of the threat they posed to food supplies for humans, but they are 
now being studied extensively because of their abilities to mediate non-Mendelian inheritance, produce 
additional prions, and display phenotypic variance (Wickner et al., 2004). They also sparked the scientific 
community’s interest when they resisted ultraviolet degradation, which suggested their replication is not 
based on nucleic acids (Speransky et al., 2001). Yeast prions are generated de novo in one of every 106 
cells, and there is little chance of isolating a prion from a wild yeast population (Nakayashiki et al., 2005). 
This incredibly limited distribution is an indication that prions are disadvantageous to their host cells and 
are selected against (Nakayashiki et al., 2005). 
 
Protein aggregates, or amyloids, are caused directly by prion proteins. These are the causative agents for 
infectious neurodegenerative diseases in humans and non-human animals. There are few non-infectious 
diseases that result from amyloids (Inge-Vechtomov, 2011). One of the defining characteristics of a prion 
is that the infectious protein creates conformational changes auto-catalytically; in other words, a prion 
interacts with other proteins to form more prions. When enough prions are formed, they can produce 
amyloid protein fibrils, which have high resistance to proteases and detergents (Inoue, 2009). These 
amyloid fibrils are characteristic of mammalian prions (Inoue, 2009). Although the structure of 
mammalian, fungal, and yeast prions are similar, there is an extremely low rate of infection when yeast or 
fungal prions are introduced to mice (Tessier and Lindquist, 2009). This means that any research 
conducted on non-mammalian prions is safe for humans. The genome of the yeast Saccharomyces 
cerevisiae contains several proteins that can assume a transmissible prion form (Resende et al., 2003). 
Therefore, it will be the model used to test for prion formation in this experiment.  
 
The URM1 gene encodes the Urm1 protein that functions as an ubiquitin-related modifier and can bind to 
amyloid-forming prions in S. cerevisiae. The protein encoded by the URM1 gene is typically referred to 
as Urm1p, where the lower-case “P” identifies it as a protein. Typical nomenclature of genetics dictates 
that genes in all capital letters, such as URM1, signify the normal, or wild-type version, of the gene. If the 
gene is written in lower case letters and is followed by a delta symbol, such as urm1Δ, it signifies that the 
gene is a deletion mutant. The protein ubiquitin is used in cells to regulate proteins by covalently binding 
to specific sites on them and tagging them for degradation by other protein complexes called proteasomes 
(Pedrioli et al., 2008). Ubiquitin-related modifying proteins are part of a family of proteins called 
ubiquitin-like proteins (UBL’s). These have been found to have similar functions as a family of sulfur-
carrying proteins in prokaryotes, although these prokaryotic proteins lack the modification functions of 
prions (Pedrioli et al., 2008).  The protein Urm1p and these sulfur-carrying proteins have a similar folding 
region of β-sheets and covalently modify proteins. Although its sequence and structure are more similar 
to the bacterial sulfur carrying proteins than to prion proteins, Urm1p can form prions (Pedrioli et al., 
2008). This has led to the suggestion that ancestral members of the UBL family were like the Urm1 
protein, which has been called a molecular fossil, and indicates it may be conserved among yeasts 
(Pedrioli et al., 2008). It has been shown in other lab experiments that if the prion-forming protein is over-
expressed, the frequency of prion formation increases as well (Wickner et al., 2004). This may result from 
gene over-expression creating an abundance of the precursor proteins for the amyloids, which then 
become modified into prions (Speransky et al., 2001). 
 
Cytoduction, or cytoplasmic mixing, measures the transmissibility of prions by observing the results of 
cell mating. Haploid yeast cells exist as one of two mating types or sexes: A and Alpha (Wickner et al., 
2004). Haploid cells of the opposite mating type can fuse (mate) to become diploid cells.  The nuclei of 
the two cells also fuse, which results in a diploid cell (one that has two sets of chromosomes). 
Cytoduction is essentially aborted mating (Wickner et al., 2004).  Although karyogamy, or fusion of the 
two nuclei, does not occur, the two cells fuse, and the cytoplasm from both cells is mixed together. If only 
one of the cells involved in the mating carries the prion, then the recipient cell will be identified as the 
cell that gains the prion (Wickner et al., 2004). Although what occurs between the cells during 
cytoduction is not completely understood, as long as karyogamy is prevented, the cells will appear to join 
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for a certain period of time and will then separate again (Wickner et al., 2004). The two haploid cells will 
form again, but with the mixed cytoplasmic contents of both cells. This measures transmissibility by 
visualizing how many of the aggregates can be transferred from one cell to another and from parent to 
daughter cell. 
 
Genetic markers are used to further distinguish between recipient and donor cells and are specific genes 
that produce recognizable traits that allow the different types of cells to be distinguished by their 
genotypic strain. For example, the genotype of yeast strains can be written as: MAT A ura2 leu2 
(Wickner et al., 2004). This describes a yeast strain that is mating type A, and carries the ura2 and leu2 
mutations, which result in a certain nutrient requirement called auxotrophy. The ura2 mutation prevents 
the cell from synthesizing the base uracil and leu2 prevents the cell from synthesizing the amino acid 
leucine, which means the MAT A ura2 leu2 strain will grow only in the presence of uracil and leucine 
(Wickner et al., 2004). Another example strain would be MAT Alpha trp1 his1, which will grow only in 
the presence of the amino acids tryptophan and histidine (Wickner et al., 2004). This auxotrophic 
phenotype allows different strains with different genotypes to be distinguished. 
 
Due to the conservation of URM1 and its relation to ubiquitin and proteasome degradation, the goal of 
this study is to determine the role of the ubiquitin-related modifier protein URM1 in prion formation in S. 
cerevisiae. My hypothesis is that if the prion exists in cells that have a synthetic abundance of the 
ubiquitin-related modifier, Urm1p, the stability of the prion will be less than that of a normal prion, thus 
making it easier to cure, and also that this less stable prion will have a higher frequency of formation. 
Also, this experiment will investigate the different effects of over-expression in both wild-type and 
deletion mutants. This research is significant because determining different methods to reduce the 
stability, thus allowing for easier degradation of the prion and yielding reduced infectivity of prions, may 
open doors to treating the diseases associated with them. 
 
Materials and Methods 
 
Amplifying DNA and Generating Viable Yeast Colonies 
 
A polymerase-chain reaction (PCR) was performed to amplify the urm1::G418 disruption cassette. This 
specific cassette contains the G418, or KanMx gene, which is a selected marker that provides resistance to 
the fungicide Geneticin. The PCR was performed by digesting the yeast cells in 30µL of Zymolyase and 
then incubating these cells at 37°C for 45 minutes. A solution of cells and PCR primers was created so 
that each of four tubes contained 50µL of premade Master Mix, 5µL of upstream primer, 5µL of 
downstream primer, 1µL of cells, and 39µL of water for a total of 100µL. PCR was run on these samples. 
The products of the PCR were subjected to gel electrophoresis. The first well of the gel was loaded with 
6µL of a known DNA ladder and DNA stain, and the next four were loaded with PCR samples. The PCR 
samples were prepared by pipetting 10µL from each PCR tube into a new, larger tube and then adding 
2µL of 6x loading dye and 1µL of the DNA stain SYBR green. The gel was allowed to run at 100 volts 
for 50 minutes. Once the DNA visibly migrated, the current was turned off and the gel was removed. A 
picture of the gel was taken using an Alpha-Imager system that exposes the gel to ultraviolet light under a 
special filter.  
 
The remaining PCR product was purified using the Promega DNA purification system. Ninety mircoliters 
from each PCR tube were transferred to a new, larger tube and 90µL of membrane binding solution were 
added. These tubes were inverted several times and then centrifuged for approximately five seconds at 
maximum speed (5000xg). The solution was pipetted into a mini-column containing a silica-bed filter, 
which was then put into a new tube and centrifuged for one minute at maximum speed. The supernatant 
was poured into a waste beaker. Seven hundred microliters of membrane wash solution were added to the 
column and then centrifuged for one minute at maximum speed. The supernatant was again poured off. 
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Five hundred microliters of membrane solution were then added to the column and centrifuged for five 
minutes at maximum speed. The flow-through was drained and the column and tube were centrifuged 
again for an additional minute. Afterwards, 50µL of DNA TE buffer were poured into the column, 
allowed to incubate for five minutes, and then centrifuged for one minute at maximum speed.  
 
These cells were transferred to a single tube of yeast extract-peptone-adenine-dextrose (YPAD) broth 
media and allowed to grow overnight. The cells were then centrifuged for five minutes at maximum 
speed. The media was poured out, leaving only the pellet. One milliliter of transformation buffer was then 
added and the cells were resuspended by mixing with a pipet. This suspension was then transferred to a 
smaller tube and centrifuged for one minute at maximum speed. The supernatant was removed by pipet, 
and 200µL of transformation buffer were added. This solution was split into two separate tubes, one for 
PCR and the other as a negative control. The PCR tube received 100µL of transformation buffer, and all 
tubes were centrifuged for one minute at maximum speed. The supernatant was removed all pellets were 
resuspended with 100µL of transform buffer. Ten microliters of carrier DNA and 500µL of Polyethylene 
Glycol (PEG) were added to each tube. The cells were mixed by pipetting slowly approximately 10 times. 
The tubes were incubated at 30°C for 30 minutes, and were then incubated in a 42°C waterbath for 15 
minutes. The tubes were centrifuged for one minute at maximum speed. Eight hundred microliters of 
supernatant were removed, and 300µL of YPAD were pipetted into each tube, mixed with cells, and then 
transferred to a larger tube. These larger tubes were centrifuged for five minutes at maximum speed. The 
supernatant was poured off and the cells were mixed with 300µL of water. This suspension was pipetted 
directly onto a plate and spread using a sterile cell spreader; the plates were incubated at 30°C for three 
days. The colonies from the PCR plates were replated to obtain pure cultures.  
 
While the pure culture plates were incubating, Eschericia coli strains containing either pH317, pER62, or 
pMP46 plasmids, were plated on LB + Ampicilin media. The pH317 is the empty plasmid, and does not 
carry the gene to produce the prion protein. The pER62 contains the wild-type version of the Ure2 gene, 
and the pMP46 gene serves as the hyper-inducer and has multiple copies of the Ure2 gene present on the 
plasmid. After incubation and growth, these cultures were transferred to broth media. Two hundred and 
fifty microliters of cell resuspension solution were added to each plasmid tube, and the cells were 
resuspended by pipetting. The plasmids were then transferred to smaller tubes. Two hundred and fifty 
microliters of cell lysis solution were added to the tubes, and the solutions were mixed by inverting the 
tubes several times. Ten microliters of alkaline protease solution were then added to protect the DNA, and 
the plasmids were mixed by inverting the tubes several times. Three hundred and fifty microliters of 
neutralization solution were added to the plasmid tubes and the tubes were inverted immediately. A 
precipitate was observed. The tubes were centrifuged for 10 minutes at top speed. New collection tubes 
and spin columns were labeled during centrifugation. The liquid was then transferred to the new, 
corresponding spin columns by pipetting, and the columns were then centrifuged at maximum speed for 
one minute. The flow-through was discarded and the column was reinserted into the collection tube. 
Seven hundred and fifty microliters of column wash solution were added to each column, and the 
columns were then centrifuged for one minute at maximum speed. Then 250µL of column wash solution 
were added to the columns, and the columns were centrifuged again at maximum speed for two minutes. 
After the supernatant was poured off, the tubes were centrifuged for one minute at maximum speed to 
dry. One hundred microliters of nuclease-free water were added to each tube, and the tubes were 
centrifuged for one minute at top speed. These were stored in the freezer for future use.  
 
The yeast cells were combined with the plasmids. One milliliter of yeast transformation buffer (YTB) was 
added to each of eight new tubes (four for mutant cells and four for wild-type cells). A large colony of 
cells was selected from each plate and added to a tube. These cells were then washed with the buffer, 
which was promptly removed by pipetting. The cells were resuspended in 400µL of YTB. Four new tubes 
were then obtained: one to contain only cells and no transformational DNA, one for the pH317 plasmid, 
one for the pER62 plasmid, and one for the pMP46 plasmid. First, 10µL of the specific plasmid were 
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added to the appropriate tube, and the tube with only cells received the same volume of YTB. One 
hundred microliters of cells and 10µL of carrier DNA were then added to each of these four tubes. Six 
hundred microliters of PEG were added to each tube and mixed by pipetting. These tubes were incubated 
at 30° C for 30 minutes, and then incubated in a water bath of 42° C for 15 minutes. The tubes were 
centrifuged for one minute at maximum speed and the supernatant was removed. The pellet was 
resuspended in 300µL of sterile water and the total volume was spread on a plate of SD-Leucine media.  
 
Frequency of Formation and Stability 
 
Six large tubes were obtained. Three were used for wild-type colonies and three were used for urm1Δ 
mutant colonies. Each was filled with five milliliters of liquid YPAD media. A single pure colony from 
the previously plated pER62 plasmid cultures was added to each tube. These six tubes were incubated in a 
shaker incubator, at 30°C for three days. These were then diluted by a factor of 20, using 950µL of 
distilled water and 50µL of cells. The absorbency of these tubes was determined by putting them in a 
spectrophotometer.  The values were recorded. The two colonies corresponding to the largest absorbency 
values were used to create a serial dilution ranging from 107 to 102. Each dilution was plated on 
SD+USA+His+Trp media (containing synthetic dextrose, ureidosuccinic acid, histidine, and tryptophan), 
except the 102 tubes that were plated on YPAD. These plates were incubated at 30°C for two days. It is 
important not to incubate the plates for too long because it has been shown that prolonged incubation is a 
second way this heavy oligomer was generated. (Thual et al., 1999). This heavy oligomer refers to the 
amyloid, and refers to the idea that a heavier oligomer will be more difficult to cure or degrade. Also, 
proper incubation time is important because it is definitively known that deletion mutants grow more 
slowly, are sensitive to temperature, and often fail to establish a mitotic spindle, so over incubating the 
plates may alter the results (Pedrioli et al., 2008). The number of yeast colonies on each plate was counted 
and recorded. This process was repeated for the pMP46 and pH317 plasmids.  
 
These colony counts represent the number of prion positive units present at a specific dilution. In order to 
determine whether these values were corrected to represent the number of USA+ cells present per one 
million cells (106). The method to correct the original colony counts depends on the number of colonies 
counted for the 102 dilutions. If the value is less than one hundred, one hundred is divided by that value, 
and the resulting factor is multiplied to all higher dilution colony counts. If the value is one hundred or 
greater, that value is then divided by one hundred to receive a decimal value. The higher dilutions are 
multiplied by a number that will make the dilution become 106, and this number is divided by the decimal 
value.  
 
Prion Maintenance and Curing 
 
I determined the stability of the prions next. Protein stability was assessed by growing the prion-
containing strains on rich media (with all nutrients) for several days and then transferring several colonies 
to the media that was used to identify [URE3] cells. Even with very stable prions, some loss occurs over 
many cell divisions. FI tested about four [URE3] colonies that carried the urm1 mutation and four 
[URE3] colonies of the URM1 wild-type. Each strain was streaked on SD-Leu (Synthetic dextrose with 
Leucine dropout mix) media in order to isolate single colonies, which were then transferred to the prion 
testing plates. The characterizing phenotype of the [URE3] prion strain is the ability to grow in the 
presence of a metabolite called ureidosuccinic acid, or USA, (in place of the nucleic acid uracil; Ross et 
al., 2005). Ten colonies from each streak were then transferred to other SD-Leu plates and arranged in a 
grid orientation. The grid was of four rows and five columns. Four of these grid plates were created, at 
least one for each plasmid tested, and two deletion mutants and two wild-type colonies. These four plates 
were allowed to incubate at 30°C for three days. These served as the master plates and were replica plated 
twice. First onto a SD+Ura+His+Trp (or Synthetic dextrose with added uracil, histadine, and tryptophan), 
and a second time onto SD+USA+His+Trp. The second plate used USA instead of uracil because uracil 
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allowed all cells to grow equally and served as a positive control to demonstrate successful replica 
plating. The USA is selective and only allows for prion growth. The replica plates were incubated with 
the master plates at 30°C for three days. The results were then photographed and the growth levels were 
compared.  
 
To test these prion colonies for curing abilities, the USA plates were examined. The four best growing 
colonies were determined and marked. The colonies on the master plates that correspond to the marked 
USA colonies were determined and used to streak on plates that were YPAD with added guanidine. These 
were streaked two per plate, for a total of eight plates. These plates were allowed to grow at 30°C for one 
day. Following incubation, these plates were replica plated back onto SD+USA+His+Trp plates, and were 
incubated at 30°C for three days. The overall growth of these replica plates was then analyzed.  
 
Results 
 
The frequency of prion formation was recorded for each of the three plasmids. The number of counted 
colonies was then corrected to show the number of prion positive cells per million cells. Table 1 shows 
the corrected values, the plasmids, colonies, and dilutions to which they correspond. Table 1 shows the 
hyper-inducing plasmid, pMP46, consistently has values that are higher than the other two plasmids. In 
regards to the pER62 plasmid, Table 1 shows the wild-type colonies have values similar to, or less than 
the Urm1Δ cultures. The pMP46 plasmid shows Wt, 2 plates had upwards of 70,000 USA+ units per 
million cells, and that while the Urm1Δ colonies has lower average USA+ units, the Urm1Δ colonies had 
a higher maximum value of 97452 USA+ units per million cells (Table 1). The pH317 plasmid shows the 
lowest values of all three plasmids, with a maximum of 281 USA+ units per million cells (Table 1). Table 
1 also shows the Urm1Δ, 1 the lowest values of the four groups, and that the other three groups have 
similar values. 
 
The replica plating technique was used to test the prion colonies obtained in the first part of the 
experiment by creating duplicate colonies and determining the intensity of growth by visual 
qualifications. The scale of growth intensity ranged from (+++), which represented very intense growth 
comparable to the positive control plate, down to (+), which represented very little growth, as well as (-), 
which indicates minimal to no growth was observed. Although there may appear to have been growth, 
these may have just been dead cells that were localized from the replica plating process. Fig. 1A, Fig. 1B, 
Fig. 1C, and Fig. 1D are all photographs of the replica plates that were quantified by visual assessments 
on the (+++) to (-) scale. This scale can best be seen in Fig. 1B, where there are differences in the size of 
the colonies that grew that are distinct in their ranges. Fig. 1A and Fig. 1B show 8 (+++) prion positive 
colonies were maintained through replica plating (Table 2); this is the highest number of conserved prion 
positive colonies among the three plasmids (Table 2). In regards to the pH317 plasmid, the Urm1 mutant 
colonies show very intense growth and very large clusters, whereas the wild-type colonies show various 
sizes and intensities (Fig. 1A and Fig. 1B). The pER62 and pMP46 plasmids show to have higher (-) 
colony growth than the pH317 plasmid (Table 2). The colonies that grew on the pER62 plate have only 
one (+++) of intense growth, and much more mild growth ((++) and (+)) (Fig. 1C and Table 2). The 
replica plates that were done on YPAD and guanidine media all yielded no visible cell growth.  
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Table 1.   
Data shows the number of colonies counted for each plate and the corrected number of USA+ colonies per 
million cells. 
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A.  
B.  
C.  
D.  
Fig. 1. 
Photographs of the replica plating. A and B represent the pH317 plasmid, with A showing Urm1 mutant 
colonies, and B showing wild-type colonies. C shows growth for the pER62 plasmid. D shows the 
growth for the pMP46 plasmid. 
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Table 2. 
The number of colonies representing various growth intensities. Each value shown is based out of 20.  
 
Discussion 
 
The pH317 plasmid was the known empty plasmid and served as the negative control. When looking at 
the results seen in Table 1, the values for all four colony groups are relatively consistent with each other. 
These values tend to be atypical of what is expected from the negative control and may have resulted 
from spontaneous induction. These greater than anticipated values may have resulted from successful 
incubation of partly formed prions, which would still form fully developed amyloids because the entire 
protein is not required in prion formation (Ross et al., 2004). Also, these may have resulted from 
spontaneous formation because it has been shown the [URE3] prion can be produced de novo in a strain 
from which it was previously absent (Masison et al., 1997). 
 
The pER62 was the test plasmid in this experiment. Table 1 shows the two colony groups that best 
demonstrate the results are Wt3 and Urm1,1. These two groups best demonstrate the expected results 
because the lower dilution cell counts were roughly ten-fold less than those of the higher dilution. As seen 
in Table 1, The Wt3 group had approximately 43 USA+ colonies per million cells for the 103 dilution, and 
had 448 USA+ colonies per million cells for the 104. This shows the ten-fold increase between dilution 
factors, as expected. In relation to the Urm1,1 group however, these values are ten-fold less, meaning the 
highest cell count was 4095 USA+ per million cells. This shows the deletion mutants yielded more prion 
formation than the wild-type colonies did.  
 
The pMP46 plasmid served as the hyper-inducer, which was used because it is known that over-
expression of the gene tends to increase the frequency of prion formation (Ross et al., 2005). The pMP46 
plasmid groups all yielded the highest observed values of USA+ colonies per million cells. This is 
consistent with other research that shows the [URE3] has an increased frequency of the prion when the 
gene coding the prion protein is over-expressed. (Masison et al., 1997).  Table 1 shows the Urm1, 2 
mutants had the highest corrected value overall, while the Wt3 group had the lowest count observed for 
this plasmid. The results of these three plasmids, showing that as the number of available prion forming 
genes increases, the number of prions increases as well, supports the hypothesis that increased expression 
increases formation. Mutltiple experiments have also been done that show that over-expressing the Ure2p 
protein domain resulted in an increase in prion formation (Ross et al., 2005).  
 
All of the replica plates that were done on media containing uracil were not pictured in Fig. 1. This was 
because, since uracil was on the media, all cells could grow, not just those containing prions. The media 
containing uracil was used as a positive control to show the replica plates containing USA in the media 
were successful. USA is ureidosuccinate, and is an important factor in identifying prions. The normal 
function of the Ure2 protein is involved in the repression of nitrogen catabolites (Ross et al., 2005). This 
nitrogen repression mechanism allows cells to take in poor nitrogen sources when otherwise deficient 
(Fernandez-Bellot et al., 2000). This means that the presence of [URE3] leads to cells gaining the ability 
to intake USA (Edskes et al., 1999). Overall, this nitrogen catabolite pathway is significant to this 
experiment because it allows all cells containing a prion to have the ability to absorb USA from the 
!"#$%&' ()*+,-.,/-"-0) 12223 1223 123 143
!"#$% & % ' (
)* + + , (
-./,0 !"#$% % , 1 %2
-#-(, )* + ( 1 &
-31%'
 Bridges 7 (Spring 2013) 
medium and convert it to the nucleotide uracil (Nakayashiki et al., 2005). Table 2 shows the pH317 
plasmid had the most sustained growth, especially in the Urm1 mutant colonies (Fig. 1A and Fig. 1B). 
The Urm1 mutant showed more colonies of sustained growth than the wild-type colonies. The pER62 and 
pMP46 plasmids had higher negative (-) values than either pH317 plasmid colony (Fig. 1C, Fig. 1B, and 
Table 2). This supports the hypothesis that the more available genes expressing the prion protein, the less 
stable the prions may be, thus meaning they are less sustainable over generations. Table 2 shows the 
pER62 plasmid to have more negative colonies than the pMP46 plasmid, however. This does not support 
the hypothesis because the plasmid with less prion protein gene had less sustainable prions. In part, this 
may be due to the pMP46 plasmid expressing so much prion protein; the amyloid may have simply been 
larger than those in pER62, and hence, may have been harder to degrade.  
 
The curing experiment that was done on YPAD and guanidine media showed no visible cellular growth, 
suggesting that all prion-containing cells were cured of their prions, and thus could not grow. Guanidine 
is a chemical that interferes with the natural chaperone proteins of the Ure2 prion proteins. One such 
chaperone protein, Hsp104, functions by partitioning the prions in the dividing cells by severing the prion 
fibers and allowing equitable division for each daughter cell (Halfmann et al., 2012). This means to 
effectively cure the cells of prions, there must be enough of the chaperone proteins to inhibit, and thus 
over-expressing the prion proteins the chaperones assist will increase the amount of chaperone proteins. 
This is known as prion curing by means of over-expression. It poses a plausible method for curing 
because more chaperone proteins would yield larger amyloids, and the larger aggregate would only be 
passed onto one of the daughter cells after division, and the other cell would be amyloid free (Speransky 
et al., 2001). This would not just benefit the pER62 and pMP46 plasmids however, because many smaller 
amyloids can be seen to eventually coalesce into a much larger aggregate naturally (Speransky et al., 
2001). Hence the pH317 was also seen to be cured because its smaller amyloids naturally created a larger 
one that was prevented from cleavage during cellular division, and results in prion free cells. It is 
important to note, however, that other experiments have shown even though these cells may have been 
cured of the prions, it has been shown that the [URE3] amyloid does has reversible curability, but these 
cured strains may form the amyloid again (Masison et al., 1997).  
 
Overall, the results support the idea that over-expression of the protein increases frequency of formation 
(Fig. 1), as well as the idea that an excess of prion protein will yield less sustainable prions. The curing 
aspect of the hypothesis is not strongly supported because there were no discernable differences between 
the plasmids in regards to curing effects. These effects may be further fine-tuned by adjusting the levels 
of guanidine in the media. Human error is always an issue in experiments, and should be accounted for 
justly. It is known for certain that prion proteins found in mammals and yeast, can transmit diseases, and 
code for heritable traits (Namy et al., 2008). It is known that a regular cellular conformation can become 
non-functional and thus cause ailments and malfunctions in host cells (Namy et al., 2008). This makes it 
important for research to continue in regards to human medicine because it has been shown that the 
presence of prions creates several phenotypes, and affect the hosts’ ability to survive (Namy et al., 2008). 
It is reasonable to suggest that if the normal function of cellular prion proteins is for neuroprotection, then 
loss of this function by prion conversion might contribute to the prion-induced neurodegeneration (Harris 
and True, 2006). As it currently stands, diagnoses of an amyloidoses is equivalent to a death sentence 
because of the human diseases that involve prions (Inge-Vechtomov, 2011). Thus this and further 
research are significant, not only to better aid in understanding the interactions between aggregates and 
inheritance-chaperone proteins, but also the possibility of modeling the mammalian diseases in yeasts 
may provide new insight into the molecular mechanism of their pathogenesis and the development of 
treatment approaches (Oshervich et al., 2004; Inge-Vechtomov, 2011). 
 
 
 
 
 Bridges 7 (Spring 2013) 
References 
 
Edskes, H., Gray, V., & Wickner, R. (1999). The [URE3] prion is an aggregated form of Ure2p that can 
be cured by over-expression of Ure2p fragments. Proceedings of the National Academy of 
Sciences, 96, 1498-1503. Retrieved from the National Center for Biotechnology Information. 
 
Fernandez-Bellot, E., Guillement, E., & Cullin, C. (2000). The yeast prion [URE3] can be greatly induced 
by a functional mutated URE2 allele. The European Molecular Biology Organization Journal, 
19(13), 3215-3222. Retrieved from the National Center for Biotechnology Information. 
 
Halfmann, R., Jarosz, D., Jones, S., Chang, A., Lancaster, A., & Lindquist, S. (2012). Prions are a 
common mechanism for phenotypic inheritance in wild yeasts. Nature, 482(7385), 363-470. 
Retrieved from the National Center for Biotechnology Information.  
 
Harris, D., & True, H. (2006). New insights into prion structure and toxicity. Neuron, 50(3), 353-357. 
Retrieved from Science Direct.  
 
Inge-Vechtomov, S. G. (2011). Yeast prions as a model of neurodegenerative infectious amyloidoses in 
humans.  Russian Journal of Developmental Biology, 42(5), 293-300. Retrieved from the 
National Center for Biotechnology Information.  
 
Inoue, Y. (2009). Life cycle of yeast prions: Propagation mediated by amyloid fibrils. Protein & Peptide 
Letters, 16, 271-276. Retrieved from Google Scholar.  
 
Masison, D., Maddelein, M.-L., & Wickner, R. (1997). The prion model for [URE3] of yeast: 
Spontaneous requirements for propagation. Proceedings of the National Academy of Sciences, 
94(23), 12503-12508. Retrieved from the Proceedings of the National Academy of Sciences of 
the United States.  
 
Nakayashiki, T., Kurtzman, C. P., Edskes, H. K., & Wickner, R. B. (2005). Yeast prions [URE3] and 
[PSI+] are diseases. Proceedings of the National Academy of Sciences of the United States of 
America, 102(30), 10575-10580. Retrieved from Proceedings of the National Academy of 
Sciences of the United States of America.  
 
Namy, O., Galopier, A., Martini, C., Matsufuji, S., Fabret, C., & Rousset J. P. (2008). Epigenetic control 
of polyamines by the prion [PSI+]. Nature cell biology, 10(9), 1069-1075. Retrieved from 
National Center for Biotechnology Information.  
 
Oshervich, L. Z., Cox, B. S., Tuite, M. F., & Weissman, J. S. (2004). Dissection and design of yeast 
prions. Public Library of Science (PLoS), 2(4), 442-451. Retrieved from the National Center of 
Biotechnology Information.  
 
Pedrioli, P., Leidel, S., & Hofmann, K. (2008). Urm1 at the crossroad of modifications. European 
Molecular Biology Organization, 9(12), 1196-1202. Retrieved from the National Center for 
Biotechnology Information.  
 
Resende, C., Outeiro, T., Sands, L., Lindquist, S., & Tuite, M. (2003). Prion protein gene polymorphisms 
in Saccharomyces cerevisiae. Molecular Microbiology, 49(4), 1005-1017.  Retrieved from the 
National Center for Biotechnology Information.  
 
 Bridges 7 (Spring 2013) 
Ross, E., Baxa, U., & Wickner, R. (2004). Scrambled prion domains form prions and amyloid. Molecular 
and Cellular Biology, 24(16), 7206-7213. Retrieved from the National Center for Biotechnology 
Information.  
 
Ross, E., Edskes, H., Terry, M., & Wickner, R. (2005). Primary sequence independence for prion 
formation. Proceedings of the National Academy of Science of the United States of America, 
102(36), 12825-12830. Retrieved from the Proceedings of the National Academy of Science of 
the United States of America.  
 
Speransky, V., Taylor, K., Edskes, H., Wickner, R., & Steven, A. (2001). Prion filament networks in 
[URE3] cells of Saccharomyces cerevisiae. The Journal of Cell Biology, 153(6), 1327-1335. 
Retrieved from the National Center for Biotechnology Information.  
 
Tessier, P., & Lindquist, S. (2009). Unraveling infectious structures, strain variants and species barriers 
for the yeast prion [PSI+]. Nature Structure & Molecular Biology, 16(6), 598-605. Retrieved 
from the National Center for Biotechnology Information.  
 
Thual, C., Komar, A., Bousset, L., Fernandez-Bellot, E., Cullin, C., & Melki, R. (1999). Structural 
characterization of Saccharomyces cerevisiae prion-like protein Ure2. The Journal of Biological 
Chemistry, 274(19), 13666-13674. Retrieved from the National Center for Biotechnology 
Information. 
 
Wickner, R., Edskes, H., Ross, E., Pierce, M., Baxa, U., Brachmann, A.,  & Shewmaker, F. (2004). Prion 
genetics: New rules for a new kind of gene. Annual review of genetics, 38, 681-707.  
 Bridges 7 (Spring 2013) 
Faculty Adviser 
 
Dr. Michael M. Pierce is an Associate Professor of Biology at Coastal Carolina 
University. His research focuses on the infectious prion diseases, and his lab is 
using the [URE3] prion of yeast as a model system to investigate the molecular 
details of amyloid fiber formation in simple eukaryotic cells. Pierce has 
published several journal articles on this topic and teaches courses on genetics 
and molecular biology. He received his Ph.D. in Biochemistry from the 
University of Texas Health Science Center and came to CCU after a post-
doctoral fellowship at the National Institutes of Health. 
 
